3 Reasons Pfizer Looks Like a No-Brainer Buy Right Now

If you're looking for an undervalued growth stock to buy right now, Pfizer (NYSE: PFE) is an investment that should be near the top of your list. While the company is facing a challenging road ahead, I'm optimistic that it can continue generating good growth with the investments and moves it has been making in recent years.Investors may be down on the company, assuming that the business will be doomed as COVID-related sales decline and patents of key drugs expire. But that's likely far from the case. Here are three reasons why taking a chance on this struggling stock could potentially be a great move for you today.Tech stocks have artificial intelligence (AI), but in healthcare, weight loss treatments are lighting a fire under companies' valuations. Pfizer hopes to benefit from that hype as it works feverishly on a weight loss pill it believes could be one of the first to hit the market soon. While there are approved weight loss injectable treatments in the market, such as Zepbound and Wegovy, there could be an even bigger opportunity for weight loss pills.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool